The lineage C.37, (Lambda variant), was recently classified as a variant of interest by the World Health Organization (WHO) based on its high circulation rates in South America, and has showed "the ability to escape from neutralizing antibodies elicited by CoronaVac."
Due to limited familiarity with providing antiretroviral medication, many participants were hesitant to initiate PrEP.
Associations found in people under the age of 45 were weaker in patients over that age.
Patients with a history of malnutrition had higher odds of developing severe disease.
Investigators wanted to study usage of F/TAF vs F/TDF in clinical practice and HIV seroconversion.
A new report, based on data from dialysis centers, suggests the US is far from reaching so-called “herd immunity.”
While a significantly reduced effectiveness was seen with 1 dose, only a small reduction was observed after 2.
Adherence for daily dosing decreased and event-driven PrEP usage increased in a Chinese study.
Impaired resilience was found to be associated with loneliness.
Virtual support services were crucial for providing continued care and education.
In a pilot project, customers were surveyed about HIV risk behaviors to gain further insights and assessed for potential PrEP utilization.
A research team working across several nursing homes sought to reduce antimicrobial use.
Many respondents reported having a lack of information about the use of PrEP.
PLWH should strictly maintain ART therapy and COVID-19 mitigation efforts.
Crowdsourcing and other approaches may develop more effective interventions to promote PS.
More tailored strategies could improve PrEP provision in family planning clinics.
A meta-analysis study found that 70% of PrEP users either stopped or had inadequate adherence within 6 months of initiation.
CDC report chronicles 20 incidents of HBV infection among recipients between 2014 and 2019.
The federal agency gives nod for fexinidazole as the first all-oral treatment for the parasitic illness.
Small survey from gay and bisexual men (GBM) inquired about their experiences during COVID-19 restrictions, and feedback on PrEP.
The case was identified in an individual who had recently returned from a trip to Nigeria.
No significant difference was observed across the 3 study groups.
A positive relationship may exist between infection severity and adaptive immunity.
In Brazil, a concerted effort of recruiting adolescents was made to go out and talk with them about PrEP.
Rates of testing for HIV, as well as PrEP uptake, remain suboptimal in MSM of color.
US residents with HIV have higher rates of mortality than their peers without infection, but the gap is narrowing, a recent study showed.
The Pasteur Act in Congress is designed to incentivize pharmaceutical companies to develop new antibiotics.
Investigators surveyed men who have sex with men (MSM) about long-acting injectable pre-exposure prophylaxis (PrEP) including attitudes towards potentially taking it and barriers to usage.
The pandemic's effect on in-person care prioritization may have indirectly influenced the rate of screening opportunities in at-risk persons.
New findings from CUSTOMIZE suggest the once-monthly injection therapy was feasibly implemented and generally favored to once-daily tablets.
